Ambulatory Cardiac Monitoring Devices Market Assessment, By Device Type [Electrocardiography (ECG) Devices, Wearable Devices, Others], By End-user [Hospitals and Clinics, Ambulatory Care Centers, Home Healthcare], By Region, Opportunities and Forecast, 20

Ambulatory Cardiac Monitoring Devices Market Assessment, By Device Type [Electrocardiography (ECG) Devices, Wearable Devices, Others], By End-user [Hospitals and Clinics, Ambulatory Care Centers, Home Healthcare], By Region, Opportunities and Forecast, 2018-2032F

Global ambulatory cardiac monitoring devices market is projected to witness a CAGR of 9.88% during the forecast period 2025-2032, growing from USD 6.97 billion in 2023 to USD 14.80 billion in 2032. Various factors supporting the market growth include rising awareness of cardiac health among individuals, increasing incidences of heart diseases, which demand suitable monitoring devices, technological advancements, and growing investments in healthcare infrastructure and services. Additionally, the outpatient trend and increased telehealth services promote the growth of remote monitoring technologies.

Ambulatory cardiac monitors record heart activity in a patient over a long period. These tools are crucial in diagnosing and managing cardiac conditions that would otherwise not be identified using routine clinical ECGs. The surge in cardiovascular diseases globally has necessitated the use of monitoring equipment. Lifestyle factors include diet, lack of physical activity, smoking, and exposure to air pollution, which have significantly contributed to this trend. According to the American College of Cardiology, the global deaths due to CVD have increased from around 12.4 million in 1990 to 19.8 million in 2022. The increasing prevalence of diseases and efforts from the government to raise awareness towards healthy lifestyles drive the global ambulatory cardiac monitoring devices market.

Multinational companies are making strategic acquisitions to enhance their cardiac monitoring products, driving growth in the ambulatory cardiac monitoring devices market. In May 2024, WearLinq, Inc. acquired AMI Cardiac Monitoring, LLC. This acquisition, combined with a recent funding round of USD 6.7 million, allows WearLinq to increase access to its advanced eWave 6-lead ECG monitor. Moreover, telehealth is also driving the market for ambulatory cardiac monitoring devices due to real-time data transmission and remote patient management. This integration boosts patient engagement and allows healthcare providers to make better, more timely decisions. With time, such devices will become increasingly available, offering fruitful opportunities for improved cardiovascular care and patient outcomes.

Growing Awareness About Cardiac Health Boosts Market Demand

Growing heart health awareness has led to a high demand for ambulatory cardiac monitoring devices. With greater public awareness of CVDs, people are becoming more proactive in seeking preventive measures and monitoring solutions. Also, organizations have increased efforts to educate the public about heart health, risk factors, and the significance of regular monitoring. All these have done much more to raise the visibility and demand for cardiac monitoring devices. On World Heart Day in September 2024, P. D. Hinduja Hospital and Medical Research Centre launched the campaign ""Unmute Your Heart."" This campaign highlighted the urgent need to prioritize heart health by adopting healthy lifestyle changes.

Similarly, in October 2024, Emcure Pharmaceuticals Ltd. launched a campaign called ""ACE YOUR HEART,"" an awareness focus on cardiovascular health in India. In this campaign, they collaborated with more than 5,000 doctors nationwide to raise awareness about heart health. The company created the record-breaking largest heart structure to show its continued commitment to heart health. Such growing initiatives by organizations support market growth. As awareness of heart health increases, it is an ideal environment for the ambulatory cardiac monitoring devices market, offering scopes for innovation and greater adoption by consumers and healthcare providers alike.

Recent Advancements in Wearable Devices are Supporting Market Growth

The newest advances in ambulatory cardiac monitoring equipment are revolutionizing the scope of cardiac monitoring because they obtain and analyze long-term cardiac information to give a more precise diagnosis. Such advancements have made ambulatory monitoring devices popular for continuous heart monitoring, providing an affordable yet efficient way to monitor vulnerable patients from their homes. The integration and advancements in signal processing bring better accuracy and accessibility. They help in the early detection of critical physiological changes for timely medical alerts. Advances in wearable technology have made patients' health data more accessible, thus promoting proactive care for cardiovascular diseases. The more healthcare becomes aligned with wearables, the more its adoption rates should also rise. Changes like this can only lead to better patient outcomes and address the growing demand for effective cardiac monitoring solutions.

Companies also invest in digital healthcare and remote patient monitoring technologies that complement ambulatory cardiac devices. In May 2024, VivaLNK, Inc. launched a complete Mobile Cardiac Telemetry (MCT) and Holter monitoring solution that integrates remote patient monitoring (RPM) technology with advanced arrhythmia detection. This approach improves patient care, simplifies deployment, and decreases costs through unified MCT and Holter monitoring technology.

ECG Devices Segment Dominates the Market

ECG devices dominate the ambulatory cardiac monitoring devices market because of their user-friendly design. Also, it effortlessly connects with mobile technologies and enables patients to track their heart activity from anywhere, thus augmenting compliance and engagement. Modern ECG devices will easily integrate with smartphones and tablets, making it easier to monitor heart health for a patient and share the data provided with their healthcare providers; thus, these features support the dominance of ECG devices in the market. At the same time, cardiac telemetry is the fastest-growing segment. The growing FDA clearance for new cardiac telemetry products shows a high demand, which provides tremendous market opportunities.

For instance, in November 2024, SmartCardia SA received FDA clearance for the company's 7-lead live ECG monitoring patch intended for Mobile Outpatient Cardiac Telemetry (OCT/MCT). This waterproof and cable-free patch allows continuous monitoring for up to 14 days. The added feature of remote live ECG monitoring alerts clinicians instantaneously about clinically significant arrhythmias. Cardiac telemetry systems provide continuous real-time monitoring, thus helping patients and allowing early intervention in heart conditions, which is necessary for treating heart conditions. Therefore, this dual trend of developing ECG devices and increased adoption of cardiac telemetry underlines the dynamic evolution of the ambulatory cardiac monitoring market.

North America to Hold Major Market Share

North America has a significant share of the ambulatory cardiac monitoring devices market. The rising heart disease cases are attributed to the market's growth in the region. The Heart Disease and Stroke Statistics: the American Heart Association (AHA) report highlights the alarming statistics. The data estimated that every 34 seconds, someone dies from CVD, and every day in the U.S., 2,552 deaths are reported from CVD. Such facts point to a critical requirement for effective cardiac monitoring solutions. The North American market is increasing due to the availability of treatment solutions on a broad spectrum of distribution channels, the intense presence of key market players, and higher awareness about heart diseases. In September 2024, InfoBionic.Ai, the leading digital health company, launched its ambulatory ECG monitoring system, MoMe.net, in Epic Showroom's Connection Hub. Such innovations, along with the growing incidence of CVD, help to expand the market in this region further and make North America the market leader in the world's ambulatory cardiac monitoring devices market. Additionally, strong reimbursement policies like Medicare spur the growth of the market. The awareness about heart health created by private and governmental organizations increases demand in the market.

Future Market Scenario (2025-2032F)

Ambulatory cardiac monitoring devices hold a very promising future with inventions like minimally invasive techniques and more advanced devices like implantable loop recorders and mobile cardiac telemetry. Favorable reimbursement policies, increased expenditure on health care, and raising awareness of heart health shall make the market highly attractive to manufacturers in this emerging landscape.

In November 2024, Monitra Healthcare Pvt. Ltd. received a U.S. patent for its advanced wireless cardiac monitoring technology. This patch-based system enhances patient compliance and diagnostic accuracy by automatically detecting its orientation and selecting electrode pairs for optimal signal quality, transmitting real-time physiological data wirelessly for analysis. Such innovations create significant market opportunities.

Companies are also upgrading their devices with AI integration that strengthens portfolios and expands the market. In July 2024, Octagos Health, Inc. raised more than USD 43 million to advance AI-driven cardiac device monitoring. Their Atlas AI platform offers continuous monitoring, accurate event detection, EHR integration, and customizable reports that improve decision-making and patient outcomes in cardiology practices.

Key Players Landscape and Outlook

Market players are strengthening their position by acquiring more regulatory approvals and launching new products. These strategies serve to help them expand their market share very effectively. In September 2024, iRhythm Technologies, Inc. received regulatory approval from Japan's PMDA for the Zio 14-day continuous ECG monitoring system. With this approval, iRhythm can obtain reimbursement from the Japanese Ministry of Health, Labour, and Welfare, thereby increasing its market presence and expanding access to its innovative ECG monitoring technology in Japan.

In June 2024, Koninklijke Philips N.V. launched Cardiac Workstation, a new platform for enhancing cardiology patient care and accelerating clinical decision-making in Europe, the Middle East, and Africa. This is a point-of-care and remote analysis of ECG data by advanced algorithms. This innovation further strengthens Philips' market presence, indicating a commitment to advanced healthcare solutions.